Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.16B |
| 2 |
JPMorgan Chase
JPM
|
+$1.03B |
| 3 |
FedEx
FDX
|
+$857M |
| 4 |
Northrop Grumman
NOC
|
+$818M |
| 5 |
Humana
HUM
|
+$811M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.16B |
| 2 |
Intel
INTC
|
+$1.38B |
| 3 |
Bank of America
BAC
|
+$1.18B |
| 4 |
Verizon
VZ
|
+$1.07B |
| 5 |
Netflix
NFLX
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.14% |
| 2 | Technology | 18.46% |
| 3 | Financials | 11.78% |
| 4 | Consumer Discretionary | 11.15% |
| 5 | Industrials | 11.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Pacira BioSciences
PCRX
$1B
| $22.5M | ﹤0.01% |
373,654
-856
| -0.2% | -$49.7K |
|
927
Cohu
COHU
$2.5B
| $22.4M | ﹤0.01% |
1,302,619
-121,301
| -9% | -$2.12M |
|
928
NetEase
NTES
$84.1B
| $22.3M | ﹤0.01% |
245,410
-257,675
| -51% | -$24.2M |
|
929
Atlanta Braves Holdings Series B
BATRK
$3.22B
| $22.3M | ﹤0.01% |
1,061,751
+393,886
| +59% | +$7.63M |
|
|
RDS.B
930
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $22.3M | ﹤0.01% |
919,820
+846,977
| +1,163% | +$24.3M |
|
|
IPG
931
DELISTED
Interpublic Group of Companies
IPG
| $22.2M | ﹤0.01% |
1,332,525
+134,068
| +11% | +$2.39M |
|
932
KKR & Co
KKR
$92.3B
| $22.1M | ﹤0.01% |
+644,165
| New | +$22.5M |
|
933
AT&T
T
$163B
| $22M | ﹤0.01% |
1,021,925
-386,190
| -27% | -$8.63M |
|
|
CDK
934
DELISTED
CDK Global, Inc.
CDK
| $21.9M | ﹤0.01% |
502,249
-188,171
| -27% | -$8.37M |
|
935
Infosys
INFY
$50.6B
| $21.8M | ﹤0.01% |
1,580,568
-68,892
| -4% | -$860K |
|
936
Caesars Entertainment
CZR
$6.14B
| $21.6M | ﹤0.01% |
+385,770
| New | +$16.9M |
|
|
CTXS
937
DELISTED
Citrix Systems Inc
CTXS
| $21.5M | ﹤0.01% |
156,480
-449
| -0.3% | -$64.2K |
|
938
AtriCure
ATRC
$2.07B
| $21.4M | ﹤0.01% |
536,571
-41,989
| -7% | -$1.78M |
|
939
Iovance Biotherapeutics
IOVA
$2.7B
| $21.3M | ﹤0.01% |
647,310
-2,122
| -0.3% | -$65.1K |
|
|
TREC
940
DELISTED
Trecora Resources
TREC
| $21.2M | ﹤0.01% |
3,460,097
| – | – |
|
941
DMC Global
BOOM
$161M
| $21.1M | ﹤0.01% |
640,876
-25,800
| -4% | -$815K |
|
|
RNAM
942
DELISTED
Avidity Biosciences
RNAM
| $21.1M | ﹤0.01% |
748,107
-126,981
| -15% | -$3.67M |
|
943
Outfront Media
OUT
$5.53B
| $20.9M | ﹤0.01% |
1,457,402
+1,173,845
| +414% | +$17.6M |
|
|
LEAP.U
944
DELISTED
Ribbit LEAP, Ltd. Units, each consisting of one Class A Ordinary Share, and one fifth of one Warrant
LEAP.U
| $20.8M | ﹤0.01% |
+1,600,919
| New | +$20.4M |
|
945
Assembly Biosciences
ASMB
$526M
| $20.8M | ﹤0.01% |
105,477
-11,175
| -10% | -$2.81M |
|
|
CSII
946
DELISTED
Cardiovascular Systems, Inc.
CSII
| $20.8M | ﹤0.01% |
527,353
-485,971
| -48% | -$15.7M |
|
947
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.7B
| $20.6M | ﹤0.01% |
350,008
+222,342
| +174% | +$12.7M |
|
948
Liberty Media Series C
FWONK
$25.8B
| $20.1M | ﹤0.01% |
572,700
-472
| -0.1% | -$16.6K |
|
949
iShares MSCI USA Min Vol Factor ETF
USMV
$24.2B
| $20M | ﹤0.01% |
313,285
-48,215
| -13% | -$3.06M |
|
950
Akebia Therapeutics
AKBA
$249M
| $19.9M | ﹤0.01% |
7,924,972
+650,249
| +9% | +$5.71M |
|
Similar funds
Wellington Management Group's Q3 2020 Portfolio in Review
As of Q3 2020, Wellington Management Group held 2,048 positions worth $483B, up 7.6% from $449B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Wellington Management Group's Q3 2020 filing shows 214 new, 682 increased, 869 reduced and 176 closed positions. Its largest new stake was nCino: 7,715,323 shares worth $598M. The largest sale was Apple, an estimated $2.16B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 24% a quarter earlier, followed by Technology and Financials.
- Wellington Management Group's largest Q3 2020 buy was nCino: 7,715,323 shares worth $598M.
- Wellington Management Group added most to Procter & Gamble in Q3 2020, an estimated $1.16B increase.
- Wellington Management Group's biggest Q3 2020 reduction was Apple, cutting an estimated $2.16B.
- Wellington Management Group fully exited Momenta Pharmaceuticals, Inc. in Q3 2020, selling an estimated $160M.
- Wellington Management Group's ten largest holdings make up 18% of its $483B portfolio in Q3 2020.
- Wellington Management Group opened 214 new positions and closed 176 in Q3 2020.
- Wellington Management Group's portfolio value rose 7.6% quarter-over-quarter to $483B.
Based on Wellington Management Group's 13F filing for Q3 2020, filed 16 Nov 2020.